Rivers et al., 1989 - Google Patents
UVA sunbeds: tanning, photoprotection, acute adverse effects and immunological changesRivers et al., 1989
View PDF- Document ID
- 4363113535986546360
- Author
- Rivers J
- Norris P
- Murphy G
- Chu A
- Midgley G
- Morris J
- Morris R
- Young A
- Hawk J
- Publication year
- Publication venue
- British Journal of Dermatology
External Links
Snippet
The effects on 31 normal subjects following exposure to sunbeds containing UVA lamps with minimal UVB emission have been compared in a double‐blind study with the effects on nine control subjects of a similar exposure course three times weekly for 4 weeks to sunbeds …
- 230000003711 photoprotective 0 title description 7
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K8/00—Cosmetic or similar toilet preparations
- A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
- A61K8/30—Cosmetic or similar toilet preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetic or similar toilet preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetic or similar toilet preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetic or similar toilet preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0645—Applicators worn by the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N2005/1092—Details
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0651—Diodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rivers et al. | UVA sunbeds: tanning, photoprotection, acute adverse effects and immunological changes | |
| Gilchrest et al. | Histologic changes associated with ultraviolet A-induced erythema in normal human skin | |
| Gschnait et al. | Induction of UV light tolerance by PUVA in patients with polymorphous light eruption | |
| Mills et al. | Ultraviolet phototherapy and photochemotherapy of acne vulgaris | |
| Garland et al. | Rising trends in melanoma an hypothesis concerning sunscreen effectiveness | |
| Ortel et al. | Polymorphous light eruption: action spectrum and photoprotection | |
| Spencer et al. | Indoor tanning: risks, benefits, and future trends | |
| MORISON et al. | In vivo effect of UV‐B on lymphocyte function | |
| Ferguson et al. | A study of cutaneous photosensitivity induced by amiodarone | |
| LeVine | Phototherapy of pityriasis lichenoides | |
| Nordlund et al. | The proliferative and toxic effects of ultraviolet light and inflammation of epidermal pigment cells | |
| Feldmeyer et al. | Phototherapy with UVB narrowband, UVA/UVBnb, and UVA1 differentially impacts serum 25-hydroxyvitamin-D3 | |
| Murphy et al. | Low‐dose ultraviolet‐B irradiation depletes human epidermal Langerhans cells | |
| Stanfield et al. | Ultraviolet A sunscreen evaluations in normal subjects | |
| International Commission on Non-Ionizing Radiation Protection | Health issues of ultraviolet tanning appliances used for cosmetic purposes | |
| Roser-Maass et al. | Protection against UV-B by UV-A-induced tan | |
| Reeve et al. | Lack of correlation between suppression of contact hypersensitivity by UV radiation and photoisomerization of epidermal urocanic acid in the hairless mouse | |
| Willis et al. | Resistant psoriasis: Combined methoxsalen-anthralin therapy | |
| HÖNIGSMANN et al. | Unscheduled DNA synthesis in normal human skin after single and combined doses of V‐A, UV‐B and UV‐A with methoxsalen (PUVA) | |
| Stegmaier | Part V: Clinical Applications of Psoralens, and Related Materials: The Use of Methoxsalen in Sun Tanning | |
| Field | Early and late normal tissue damage after fast neutrons | |
| Diffey et al. | An evaluation of sunscreens in patients with broad action‐spectrum photosensitivity | |
| Leenutaphong | Hydroa vacciniforme: an unusual clinical manifestation | |
| Nonaka et al. | Photoprotective adaptation: some quantitative aspects | |
| Bullock et al. | The influence of ultraviolet‐B radiation on the mechanism of wound repair in the skin of the Atlantic salmon, Salmo salar L. |